BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reedijk M, Odorcic S, Chang L, Zhang H, Miller N, Mccready DR, Lockwood G, Egan SE. High-level Coexpression of JAG1 and NOTCH1 Is Observed in Human Breast Cancer and Is Associated with Poor Overall Survival. Cancer Res 2005;65:8530-7. [DOI: 10.1158/0008-5472.can-05-1069] [Cited by in Crossref: 516] [Cited by in F6Publishing: 296] [Article Influence: 30.4] [Reference Citation Analysis]
Number Citing Articles
1 Du X, Cheng Z, Wang YH, Guo ZH, Zhang SQ, Hu JK, Zhou ZG. Role of Notch signaling pathway in gastric cancer: A meta-analysis of the literature. World J Gastroenterol 2014; 20(27): 9191-9199 [PMID: 25083094 DOI: 10.3748/wjg.v20.i27.9191] [Cited by in F6Publishing: 31] [Reference Citation Analysis]
2 Moore G, Annett S, McClements L, Robson T. Top Notch Targeting Strategies in Cancer: A Detailed Overview of Recent Insights and Current Perspectives. Cells 2020;9:E1503. [PMID: 32575680 DOI: 10.3390/cells9061503] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
3 Jeong W, Bae H, Lim W, Song G. Dicer1, AGO3, and AGO4 microRNA machinery genes are differentially expressed in developing female reproductive organs and overexpressed in cancerous ovaries of chickens. J Anim Sci 2017;95:4857-68. [PMID: 29293730 DOI: 10.2527/jas2017.1846] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Anusewicz D, Orzechowska M, Bednarek AK. Notch Signaling Pathway in Cancer-Review with Bioinformatic Analysis. Cancers (Basel) 2021;13:768. [PMID: 33673145 DOI: 10.3390/cancers13040768] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Muellner MK, Uras IZ, Gapp BV, Kerzendorfer C, Smida M, Lechtermann H, Craig-Mueller N, Colinge J, Duernberger G, Nijman SM. A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer. Nat Chem Biol. 2011;7:787-793. [PMID: 21946274 DOI: 10.1038/nchembio.695] [Cited by in Crossref: 123] [Cited by in F6Publishing: 112] [Article Influence: 11.2] [Reference Citation Analysis]
6 Yan T, Wu M, Lv S, Hu Q, Xu W, Zeng A, Huang K, Zhu X. Exosomes derived from microRNA-512-5p-transfected bone mesenchymal stem cells inhibit glioblastoma progression by targeting JAG1. Aging (Albany NY) 2021;13:9911-26. [PMID: 33795521 DOI: 10.18632/aging.202747] [Reference Citation Analysis]
7 Lee CW, Raskett CM, Prudovsky I, Altieri DC. Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. Cancer Res. 2008;68:5273-5281. [PMID: 18593928 DOI: 10.1158/0008-5472.can-07-6673] [Cited by in Crossref: 88] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]
8 Liubomirski Y, Lerrer S, Meshel T, Morein D, Rubinstein-Achiasaf L, Sprinzak D, Wiemann S, Körner C, Ehrlich M, Ben-Baruch A. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer. Front Immunol 2019;10:804. [PMID: 31105691 DOI: 10.3389/fimmu.2019.00804] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
9 Chen Y, Wu Q, Lin J, Wei J. DARS-AS1 accelerates the proliferation of cervical cancer cells via miR-628-5p/JAG1 axis to activate Notch pathway. Cancer Cell Int 2020;20:535. [PMID: 33292218 DOI: 10.1186/s12935-020-01592-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Yu T, Han C, Zhu G, Liao X, Qin W, Yang C, Liu Z, Su H, Liu X, Yu L, Liu Z, Lu S, Chen Z, Liang Y, Huang J, Qin X, Gui Y, Li J, Peng T. Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma. Cancer Med 2017;6:1587-600. [PMID: 28568708 DOI: 10.1002/cam4.1077] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
11 Simon DP, Giordano TJ, Hammer GD. Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma. Clin Cancer Res 2012;18:2452-64. [PMID: 22427350 DOI: 10.1158/1078-0432.CCR-11-2371] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
12 Mittal S, Sharma A, Balaji SA, Gowda MC, Dighe RR, Kumar RV, Rangarajan A. Coordinate hyperactivation of Notch1 and Ras/MAPK pathways correlates with poor patient survival: novel therapeutic strategy for aggressive breast cancers. Mol Cancer Ther 2014;13:3198-209. [PMID: 25253780 DOI: 10.1158/1535-7163.MCT-14-0280] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 4.1] [Reference Citation Analysis]
13 Liu SH, Shen PC, Chen CY, Hsu AN, Cho YC, Lai YL, Chen FH, Li CY, Wang SC, Chen M, Chung IF, Cheng WC. DriverDBv3: a multi-omics database for cancer driver gene research. Nucleic Acids Res 2020;48:D863-70. [PMID: 31701128 DOI: 10.1093/nar/gkz964] [Cited by in Crossref: 21] [Cited by in F6Publishing: 36] [Article Influence: 10.5] [Reference Citation Analysis]
14 Freudenberg JA, Wang Q, Katsumata M, Drebin J, Nagatomo I, Greene MI. The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies. Exp Mol Pathol. 2009;87:1-11. [PMID: 19450579 DOI: 10.1016/j.yexmp.2009.05.001] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 4.5] [Reference Citation Analysis]
15 Dyczynska E, Syta E, Sun D, Zolkiewska A. Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein. Int J Cancer 2008;122:2634-40. [PMID: 18241035 DOI: 10.1002/ijc.23405] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
16 Harbuzariu A, Oprea-Ilies GM, Gonzalez-Perez RR. The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer. Medicines (Basel) 2018;5:E68. [PMID: 30004402 DOI: 10.3390/medicines5030068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
17 Hao L, Rizzo P, Osipo C, Pannuti A, Wyatt D, Cheung LW, Sonenshein G, Osborne BA, Miele L. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells. Oncogene 2010;29:201-13. [PMID: 19838210 DOI: 10.1038/onc.2009.323] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 6.8] [Reference Citation Analysis]
18 Capaccione KM, Pine SR. The Notch signaling pathway as a mediator of tumor survival. Carcinogenesis 2013;34:1420-30. [PMID: 23585460 DOI: 10.1093/carcin/bgt127] [Cited by in Crossref: 154] [Cited by in F6Publishing: 148] [Article Influence: 17.1] [Reference Citation Analysis]
19 Guo J, Zhang CD, An JX, Xiao YY, Shao S, Zhou NM, Dai DQ. Expression of miR-634 in gastric carcinoma and its effects on proliferation, migration, and invasion of gastric cancer cells. Cancer Med 2018;7:776-87. [PMID: 29464926 DOI: 10.1002/cam4.1204] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
20 Kong D, Hughes CJ, Ford HL. Cellular Plasticity in Breast Cancer Progression and Therapy. Front Mol Biosci 2020;7:72. [PMID: 32391382 DOI: 10.3389/fmolb.2020.00072] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
21 Ahn JS, Ann EJ, Kim MY, Yoon JH, Lee HJ, Jo EH, Lee K, Lee JS, Park HS. Autophagy negatively regulates tumor cell proliferation through phosphorylation dependent degradation of the Notch1 intracellular domain. Oncotarget 2016;7:79047-63. [PMID: 27806347 DOI: 10.18632/oncotarget.12986] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
22 Lee YM, Lee JY, Ho CC, Hong QS, Yu SL, Tzeng CR, Yang PC, Chen HW. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells. Breast Cancer Res. 2011;13:R116. [PMID: 22113133 DOI: 10.1186/bcr3059] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
23 Zengin T, Ekinci B, Kucukkose C, Yalcin-Ozuysal O. IRF6 Is Involved in the Regulation of Cell Proliferation and Transformation in MCF10A Cells Downstream of Notch Signaling. PLoS One 2015;10:e0132757. [PMID: 26161746 DOI: 10.1371/journal.pone.0132757] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
24 Jin S, Mutvei AP, Chivukula IV, Andersson ER, Ramsköld D, Sandberg R, Lee KL, Kronqvist P, Mamaeva V, Ostling P. Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKβ. Oncogene. 2013;32:4892-4902. [PMID: 23178494 DOI: 10.1038/onc.2012.517] [Cited by in Crossref: 82] [Cited by in F6Publishing: 78] [Article Influence: 8.2] [Reference Citation Analysis]
25 Marignol L, Rivera-Figueroa K, Lynch T, Hollywood D. Hypoxia, notch signalling, and prostate cancer. Nat Rev Urol 2013;10:405-13. [PMID: 23712204 DOI: 10.1038/nrurol.2013.110] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.7] [Reference Citation Analysis]
26 Hu X, Huang P, Wang J, He W, Zhao P, Yao G, Ye C. [MiR-433 reverses chemoresistance to docetaxel by targeting Notch1 in breast cancer cells]. Nan Fang Yi Ke Da Xue Xue Bao 2018;38:888-94. [PMID: 33168512 DOI: 10.3969/j.issn.1673-4254.2018.07.20] [Reference Citation Analysis]
27 Hsu EC, Kulp SK, Huang HL, Tu HJ, Salunke SB, Sullivan NJ, Sun D, Wicha MS, Shapiro CL, Chen CS. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae. Neoplasia 2015;17:497-508. [PMID: 26152358 DOI: 10.1016/j.neo.2015.06.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
28 Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, Shetty K, Johnson L, Reddy EP. Liver stem cells and hepatocellular carcinoma. Hepatology. 2009;49:318-329. [PMID: 19111019 DOI: 10.1002/hep.22704.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Abbaszadegan MR, Taghehchian N, Li L, Aarabi A, Moghbeli M. Contribution of KCTD12 to esophageal squamous cell carcinoma. BMC Cancer 2018;18:853. [PMID: 30157793 DOI: 10.1186/s12885-018-4765-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
30 Lu M, Sha Y, Silva TC, Colaprico A, Sun X, Ban Y, Wang L, Lehmann BD, Chen XS. LR Hunting: A Random Forest Based Cell-Cell Interaction Discovery Method for Single-Cell Gene Expression Data. Front Genet 2021;12:708835. [PMID: 34497635 DOI: 10.3389/fgene.2021.708835] [Reference Citation Analysis]
31 Zhang C, Mo R, Yin B, Zhou L, Liu Y, Fan J. Tumor suppressor microRNA-34a inhibits cell proliferation by targeting Notch1 in renal cell carcinoma. Oncol Lett 2014;7:1689-94. [PMID: 24765202 DOI: 10.3892/ol.2014.1931] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
32 Zarone MR, Misso G, Grimaldi A, Zappavigna S, Russo M, Amler E, Di Martino MT, Amodio N, Tagliaferri P, Tassone P, Caraglia M. Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment. Sci Rep 2017;7:17949. [PMID: 29263373 DOI: 10.1038/s41598-017-18186-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
33 Sun Y, Zhang R, Zhou S, Ji Y. Overexpression of Notch1 is associated with the progression of cervical cancer. Oncol Lett 2015;9:2750-6. [PMID: 26137140 DOI: 10.3892/ol.2015.3143] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
34 Xing F, Okuda H, Watabe M, Kobayashi A, Pai SK, Liu W, Pandey PR, Fukuda K, Hirota S, Sugai T. Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells. Oncogene. 2011;30:4075-4086. [PMID: 21499308 DOI: 10.1038/onc.2011.122] [Cited by in Crossref: 133] [Cited by in F6Publishing: 125] [Article Influence: 12.1] [Reference Citation Analysis]
35 Bakrania AK, Variya BC, Patel SS. Role of β-Interferon Inducer (DEAE-Dextran) in Tumorigenesis by VEGF and NOTCH1 Inhibition along with Apoptosis Induction. Front Pharmacol 2017;8:930. [PMID: 29311933 DOI: 10.3389/fphar.2017.00930] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
36 Diluvio G, Del Gaudio F, Giuli MV, Franciosa G, Giuliani E, Palermo R, Besharat ZM, Pignataro MG, Vacca A, d'Amati G, Maroder M, Talora C, Capalbo C, Bellavia D, Checquolo S. NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest. Oncogenesis 2018;7:42. [PMID: 29795369 DOI: 10.1038/s41389-018-0051-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
37 Kim MH, Kim HB, Yoon SP, Lim SC, Cha MJ, Jeon YJ, Park SG, Chang IY, You HJ. Colon cancer progression is driven by APEX1-mediated upregulation of Jagged. J Clin Invest 2013:65521. [PMID: 23863623 DOI: 10.1172/JCI65521] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
38 Xia J, Li Y, Yang Q, Mei C, Chen Z, Bao B, Ahmad A, Miele L, Sarkar FH, Wang Z. Arsenic trioxide inhibits cell growth and induces apoptosis through inactivation of notch signaling pathway in breast cancer. Int J Mol Sci 2012;13:9627-41. [PMID: 22949821 DOI: 10.3390/ijms13089627] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
39 Suman S, Das TP, Ankem MK, Damodaran C. Targeting Notch Signaling in Colorectal Cancer. Curr Colorectal Cancer Rep. 2014;10:411-416. [PMID: 25395896 DOI: 10.1007/s11888-014-0252-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
40 Liu JC, Voisin V, Bader GD, Deng T, Pusztai L, Symmans WF, Esteva FJ, Egan SE, Zacksenhaus E. Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα- breast cancer. Proc Natl Acad Sci U S A 2012;109:5832-7. [PMID: 22460789 DOI: 10.1073/pnas.1201105109] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
41 Storci G, Sansone P, Mari S, D’Uva G, Tavolari S, Guarnieri T, Taffurelli M, Ceccarelli C, Santini D, Chieco P. TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype. J Cell Physiol. 2010;225:682-691. [PMID: 20509143 DOI: 10.1002/jcp.22264] [Cited by in Crossref: 113] [Cited by in F6Publishing: 110] [Article Influence: 9.4] [Reference Citation Analysis]
42 Orzechowska M, Jędroszka D, Bednarek AK. Common profiles of Notch signaling differentiate disease-free survival in luminal type A and triple negative breast cancer. Oncotarget 2017;8:6013-32. [PMID: 27888801 DOI: 10.18632/oncotarget.13451] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
43 McCaw TR, Inga E, Chen H, Jaskula-Sztul R, Dudeja V, Bibb JA, Ren B, Rose JB. Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance. Oncologist 2021;26:e608-21. [PMID: 33284507 DOI: 10.1002/onco.13627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Abravanel DL, Belka GK, Pan TC, Pant DK, Collins MA, Sterner CJ, Chodosh LA. Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy. J Clin Invest 2015;125:2484-96. [PMID: 25961456 DOI: 10.1172/JCI74883] [Cited by in Crossref: 72] [Cited by in F6Publishing: 51] [Article Influence: 10.3] [Reference Citation Analysis]
45 Olsauskas-Kuprys R, Zlobin A, Osipo C. Gamma secretase inhibitors of Notch signaling. Onco Targets Ther 2013;6:943-55. [PMID: 23901284 DOI: 10.2147/OTT.S33766] [Cited by in Crossref: 27] [Cited by in F6Publishing: 67] [Article Influence: 3.0] [Reference Citation Analysis]
46 Rangel MC, Bertolette D, Castro NP, Klauzinska M, Cuttitta F, Salomon DS. Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer. Breast Cancer Res Treat 2016;156:211-26. [PMID: 26968398 DOI: 10.1007/s10549-016-3746-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 9.2] [Reference Citation Analysis]
47 Asnaghi L, Tripathy A, Yang Q, Kaur H, Hanaford A, Yu W, Eberhart CG. Targeting Notch signaling as a novel therapy for retinoblastoma. Oncotarget 2016;7:70028-44. [PMID: 27661116 DOI: 10.18632/oncotarget.12142] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
48 Abetov D, Mustapova Z, Saliev T, Bulanin D. Biomarkers and signaling pathways of colorectal cancer stem cells. Tumour Biol. 2015;36:1339-1353. [PMID: 25680406 DOI: 10.1007/s13277-015-3198-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
49 Geles KG, Gao Y, Giannakou A, Sridharan L, Yamin TT, Zhang J, Karim R, Bard J, Piche-Nicholas N, Charati M, Maderna A, Lucas J, Golas J, Guffroy M, Pirie-Shepherd S, Roy M, Qian J, Franks T, Zhong W, O'Donnell CJ, Tchistiakova L, Gerber HP, Sapra P. NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells. Cell Rep Med 2021;2:100279. [PMID: 34095881 DOI: 10.1016/j.xcrm.2021.100279] [Reference Citation Analysis]
50 Reedijk M, Odorcic S, Zhang H, Chetty R, Tennert C, Dickson BC, Lockwood G, Gallinger S, Egan SE. Activation of Notch signaling in human colon adenocarcinoma. Int J Oncol. 2008;33:1223-1229. [PMID: 19020755 DOI: 10.3892/ijo_00000112] [Cited by in Crossref: 9] [Cited by in F6Publishing: 79] [Article Influence: 0.7] [Reference Citation Analysis]
51 Zhong Y, Shen S, Zhou Y, Mao F, Lin Y, Guan J, Xu Y, Zhang S, Liu X, Sun Q. NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells. Onco Targets Ther 2016;9:6865-71. [PMID: 27853380 DOI: 10.2147/OTT.S109606] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
52 Takebe N, Nguyen D, Yang SX. Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther. 2014;141:140-149. [PMID: 24076266 DOI: 10.1016/j.pharmthera.2013.09.005] [Cited by in Crossref: 240] [Cited by in F6Publishing: 229] [Article Influence: 26.7] [Reference Citation Analysis]
53 Xu J, Chen Y, Olopade OI. MYC and Breast Cancer. Genes Cancer 2010;1:629-40. [PMID: 21779462 DOI: 10.1177/1947601910378691] [Cited by in Crossref: 163] [Cited by in F6Publishing: 157] [Article Influence: 14.8] [Reference Citation Analysis]
54 Ye QF, Zhang YC, Peng XQ, Long Z, Ming YZ, He LY. Silencing Notch-1 induces apoptosis and increases the chemosensitivity of prostate cancer cells to docetaxel through Bcl-2 and Bax. Oncol Lett 2012;3:879-84. [PMID: 22741011 DOI: 10.3892/ol.2012.572] [Cited by in Crossref: 6] [Cited by in F6Publishing: 37] [Article Influence: 0.6] [Reference Citation Analysis]
55 Kim SH, Hahm ER, Arlotti JA, Samanta SK, Moura MB, Thorne SH, Shuai Y, Anderson CJ, White AG, Lokshin A, Lee J, Singh SV. Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown. Breast Cancer Res Treat 2016;157:41-54. [PMID: 27097807 DOI: 10.1007/s10549-016-3795-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
56 Stojnev S, Krstic M, Ristic-Petrovic A, Stefanovic V, Hattori T. Gastric cancer stem cells: therapeutic targets. Gastric Cancer. 2014;17:13-25. [PMID: 23563919 DOI: 10.1007/s10120-013-0254-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
57 Dufraine J, Funahashi Y, Kitajewski J. Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene. 2008;27:5132-5137. [PMID: 18758482 DOI: 10.1038/onc.2008.227] [Cited by in Crossref: 180] [Cited by in F6Publishing: 174] [Article Influence: 12.9] [Reference Citation Analysis]
58 Jue C, Lin C, Zhisheng Z, Yayun Q, Feng J, Min Z, Haibo W, Youyang S, Hisamitsu T, Shintaro I, Shiyu G, Yanqing L. Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling. Oncotarget 2017;8:2501-13. [PMID: 27705934 DOI: 10.18632/oncotarget.12388] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
59 Bane AL, Pinnaduwage D, Colby S, Reedijk M, Egan SE, Bull SB, O'Malley FP, Andrulis IL. Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors. Breast Cancer Res Treat 2009;117:183-91. [PMID: 18563556 DOI: 10.1007/s10549-008-0087-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
60 Azzam DJ, Zhao D, Sun J, Minn AJ, Ranganathan P, Drews-Elger K, Han X, Picon-Ruiz M, Gilbert CA, Wander SA. Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ-secretase inhibitor drug responses. EMBO Mol Med. 2013;5:1502-1522. [PMID: 23982961 DOI: 10.1002/emmm.201302558] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
61 Sholler GS, Currier EA, Dutta A, Slavik MA, Illenye SA, Mendonca MC, Dragon J, Roberts SS, Bond JP. PCI-24781 (abexinostat), a novel histone deacetylase inhibitor, induces reactive oxygen species-dependent apoptosis and is synergistic with bortezomib in neuroblastoma. J Cancer Ther Res 2013;2:21. [PMID: 25520806 DOI: 10.7243/2049-7962-2-21] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
62 Li L, Zhao F, Lu J, Li T, Yang H, Wu C, Liu Y. Notch-1 signaling promotes the malignant features of human breast cancer through NF-κB activation. PLoS One 2014;9:e95912. [PMID: 24760075 DOI: 10.1371/journal.pone.0095912] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 6.0] [Reference Citation Analysis]
63 Pandya K, Meeke K, Clementz AG, Rogowski A, Roberts J, Miele L, Albain KS, Osipo C. Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence. Br J Cancer. 2011;105:796-806. [PMID: 21847123 DOI: 10.1038/bjc.2011.321] [Cited by in Crossref: 89] [Cited by in F6Publishing: 87] [Article Influence: 8.1] [Reference Citation Analysis]
64 Yang J, Xing H, Lu D, Wang J, Li B, Tang J, Gu F, Hong L. Role of Jagged1/STAT3 signalling in platinum-resistant ovarian cancer. J Cell Mol Med. 2019;23:4005-4018. [PMID: 30993885 DOI: 10.1111/jcmm.14286] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
65 Chao MW, Chu PC, Chuang HC, Shen FH, Chou CC, Hsu EC, Himmel LE, Huang HL, Tu HJ, Kulp SK, Teng CM, Chen CS. Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability. Oncotarget 2016;7:1796-807. [PMID: 26625202 DOI: 10.18632/oncotarget.6427] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
66 Christgen M, Geffers R, Ballmaier M, Christgen H, Poczkaj J, Krech T, Kreipe H, Lehmann U. Down-regulation of the fetal stem cell factor SOX17 by H33342: a mechanism responsible for differential gene expression in breast cancer side population cells. J Biol Chem 2010;285:6412-8. [PMID: 20040597 DOI: 10.1074/jbc.M109.082941] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
67 Shi W, Harris AL. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials. J Mammary Gland Biol Neoplasia. 2006;11:41-52. [PMID: 16947085 DOI: 10.1007/s10911-006-9011-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
68 Zhang Y, Xie ZY, Guo XT, Xiao XH, Xiong LX. Notch and breast cancer metastasis: Current knowledge, new sights and targeted therapy. Oncol Lett 2019;18:2743-55. [PMID: 31452752 DOI: 10.3892/ol.2019.10653] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
69 Weaver KL, Alves-Guerra MC, Jin K, Wang Z, Han X, Ranganathan P, Zhu X, DaSilva T, Liu W, Ratti F, Demarest RM, Tzimas C, Rice M, Vasquez-Del Carpio R, Dahmane N, Robbins DJ, Capobianco AJ. NACK is an integral component of the Notch transcriptional activation complex and is critical for development and tumorigenesis. Cancer Res 2014;74:4741-51. [PMID: 25038227 DOI: 10.1158/0008-5472.CAN-14-1547] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
70 Westhoff B, Colaluca IN, D’Ario G, Donzelli M, Tosoni D, Volorio S, Pelosi G, Spaggiari L, Mazzarol G, Viale G. Alterations of the Notch pathway in lung cancer. Proc Natl Acad Sci USA. 2009;106:22293-22298. [PMID: 20007775 DOI: 10.1073/pnas.0907781106] [Cited by in Crossref: 256] [Cited by in F6Publishing: 254] [Article Influence: 19.7] [Reference Citation Analysis]
71 Zhang X, Liu X, Luo J, Xiao W, Ye X, Chen M, Li Y, Zhang GJ. Notch3 inhibits epithelial-mesenchymal transition by activating Kibra-mediated Hippo/YAP signaling in breast cancer epithelial cells. Oncogenesis 2016;5:e269. [PMID: 27841855 DOI: 10.1038/oncsis.2016.67] [Cited by in Crossref: 39] [Cited by in F6Publishing: 46] [Article Influence: 6.5] [Reference Citation Analysis]
72 Locatelli MA, Aftimos P, Dees EC, LoRusso PM, Pegram MD, Awada A, Huang B, Cesari R, Jiang Y, Shaik MN, Kern KA, Curigliano G. Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer. Oncotarget 2017;8:2320-8. [PMID: 27906684 DOI: 10.18632/oncotarget.13727] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 9.3] [Reference Citation Analysis]
73 Lee HW, Kim SJ, Choi IJ, Song J, Chun KH. Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer. Clin Exp Metastasis 2015;32:593-603. [PMID: 26134677 DOI: 10.1007/s10585-015-9730-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
74 Oliphant MUJ, Kong D, Zhou H, Lewis MT, Ford HL. Two Sides of the Same Coin: The Role of Developmental pathways and pluripotency factors in normal mammary stem cells and breast cancer metastasis. J Mammary Gland Biol Neoplasia 2020;25:85-102. [PMID: 32323111 DOI: 10.1007/s10911-020-09449-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
75 Zhou L, Zhang N, Song W, You N, Li Q, Sun W, Zhang Y, Wang D, Dou K. The significance of Notch1 compared with Notch3 in high metastasis and poor overall survival in hepatocellular carcinoma. PLoS One 2013;8:e57382. [PMID: 23468978 DOI: 10.1371/journal.pone.0057382] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
76 Lee CW, Simin K, Liu Q, Plescia J, Guha M, Khan A, Hsieh CC, Altieri DC. A functional Notch-survivin gene signature in basal breast cancer. Breast Cancer Res. 2008;10:R97. [PMID: 19025652 DOI: 10.1186/bcr2200] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 5.9] [Reference Citation Analysis]
77 Zhu Y, Luo M, Brooks M, Clouthier SG, Wicha MS. Biological and clinical significance of cancer stem cell plasticity. Clin Transl Med 2014;3:32. [PMID: 26932376 DOI: 10.1186/s40169-014-0032-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
78 Kikuchi H, Sakakibara-Konishi J, Furuta M, Yokouchi H, Nishihara H, Yamazaki S, Uramoto H, Tanaka F, Harada M, Akie K, Sugaya F, Fujita Y, Takamura K, Kojima T, Harada T, Higuchi M, Honjo O, Minami Y, Watanabe N, Oizumi S, Suzuki H, Ishida T, Dosaka-Akita H, Isobe H, Munakata M, Nishimura M. Expression of Notch1 and Numb in small cell lung cancer. Oncotarget 2017;8:10348-58. [PMID: 28060745 DOI: 10.18632/oncotarget.14411] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
79 Huynh C, Poliseno L, Segura MF, Medicherla R, Haimovic A, Menendez S, Shang S, Pavlick A, Shao Y, Darvishian F, Boylan JF, Osman I, Hernando E. The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanoma. PLoS One 2011;6:e25264. [PMID: 21980408 DOI: 10.1371/journal.pone.0025264] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
80 Prokopi M, Kousparou CA, Epenetos AA. The Secret Role of microRNAs in Cancer Stem Cell Development and Potential Therapy: A Notch-Pathway Approach. Front Oncol. 2015;4:389. [PMID: 25717438 DOI: 10.3389/fonc.2014.00389] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
81 Rahmani Barouji S, Shahabi A, Torbati M, Fazljou SMB, Yari Khosroushahi A. Mummy Induces Apoptosis Through Inhibiting of Epithelial-Mesenchymal Transition (EMT) in Human Breast Cancer Cells. Galen Med J 2020;9:e1812. [PMID: 34466597 DOI: 10.31661/gmj.v9i0.1812] [Reference Citation Analysis]
82 Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L, Sarkar FH. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett 2011;307:26-36. [PMID: 21463919 DOI: 10.1016/j.canlet.2011.03.012] [Cited by in Crossref: 213] [Cited by in F6Publishing: 211] [Article Influence: 19.4] [Reference Citation Analysis]
83 Jamdade VS, Sethi N, Mundhe NA, Kumar P, Lahkar M, Sinha N. Therapeutic targets of triple-negative breast cancer: a review. Br J Pharmacol. 2015;172:4228-4237. [PMID: 26040571 DOI: 10.1111/bph.13211] [Cited by in Crossref: 94] [Cited by in F6Publishing: 95] [Article Influence: 13.4] [Reference Citation Analysis]
84 Belandia B, Parker MG. Nuclear receptor regulation gears up another Notch. Nucl Recept Signal 2006;4:e001. [PMID: 16604164 DOI: 10.1621/nrs.04001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
85 Chen W, Wei W, Yu L, Ye Z, Huang F, Zhang L, Hu S, Cai C. Mammary Development and Breast Cancer: a Notch Perspective. J Mammary Gland Biol Neoplasia 2021. [PMID: 34374886 DOI: 10.1007/s10911-021-09496-1] [Reference Citation Analysis]
86 Yu XM, Jaskula-Sztul R, Georgen MR, Aburjania Z, Somnay YR, Leverson G, Sippel RS, Lloyd RV, Johnson BP, Chen H. Notch1 Signaling Regulates the Aggressiveness of Differentiated Thyroid Cancer and Inhibits SERPINE1 Expression. Clin Cancer Res 2016;22:3582-92. [PMID: 26847059 DOI: 10.1158/1078-0432.CCR-15-1749] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
87 Meisel CT, Porcheri C, Mitsiadis TA. Cancer Stem Cells, Quo Vadis? Cells. 2020;9:1879. [PMID: 32796631 DOI: 10.3390/cells9081879] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
88 Das A, Narayanam MK, Paul S, Mukhnerjee P, Ghosh S, Dastidar DG, Chakrabarty S, Ganguli A, Basu B, Pal M, Chatterji U, Banerjee SK, Karmakar P, Kumar D, Chakrabarti G. A novel triazole, NMK-T-057, induces autophagic cell death in breast cancer cells by inhibiting γ-secretase-mediated activation of Notch signaling. J Biol Chem 2019;294:6733-50. [PMID: 30824542 DOI: 10.1074/jbc.RA119.007671] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
89 Janghorban M, Xin L, Rosen JM, Zhang XH. Notch Signaling as a Regulator of the Tumor Immune Response: To Target or Not To Target? Front Immunol 2018;9:1649. [PMID: 30061899 DOI: 10.3389/fimmu.2018.01649] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
90 Diaz-Padilla I, Hirte H, Oza AM, Clarke BA, Cohen B, Reedjik M, Zhang T, Kamel-Reid S, Ivy SP, Hotte SJ. A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors. Invest New Drugs. 2013;31:1182-1191. [PMID: 23860641 DOI: 10.1007/s10637-013-0001-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
91 Park HJ, Kim SR, Kim SS, Wee HJ, Bae MK, Ryu MH, Bae SK. Visfatin promotes cell and tumor growth by upregulating Notch1 in breast cancer. Oncotarget 2014;5:5087-99. [PMID: 24970818 DOI: 10.18632/oncotarget.2086] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
92 Kim AC, Barlaskar FM, Heaton JH, Else T, Kelly VR, Krill KT, Scheys JO, Simon DP, Trovato A, Yang WH, Hammer GD. In search of adrenocortical stem and progenitor cells. Endocr Rev 2009;30:241-63. [PMID: 19403887 DOI: 10.1210/er.2008-0039] [Cited by in Crossref: 92] [Cited by in F6Publishing: 84] [Article Influence: 7.1] [Reference Citation Analysis]
93 Thakur G, Kumar R, Kim SB, Lee SY, Lee SL, Rho GJ. Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma. Biomedicines 2021;9:178. [PMID: 33670230 DOI: 10.3390/biomedicines9020178] [Reference Citation Analysis]
94 Kumar S, Srivastav RK, Wilkes DW, Ross T, Kim S, Kowalski J, Chatla S, Zhang Q, Nayak A, Guha M, Fuchs SY, Thomas C, Chakrabarti R. Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer. Oncogene 2019;38:2092-107. [PMID: 30442981 DOI: 10.1038/s41388-018-0562-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
95 Wang D, Xu J, Liu B, He X, Zhou L, Hu X, Qiao F, Zhang A, Xu X, Zhang H, Wicha MS, Zhang L, Shao ZM, Liu S. IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancer. Cell Death Differ 2018;25:330-9. [PMID: 29027990 DOI: 10.1038/cdd.2017.162] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
96 Pagliaro L, Sorrentino C, Roti G. Targeting Notch Trafficking and Processing in Cancers. Cells 2020;9:E2212. [PMID: 33003595 DOI: 10.3390/cells9102212] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
97 Takeuchi H, Haltiwanger RS. Significance of glycosylation in Notch signaling. Biochem Biophys Res Commun 2014;453:235-42. [PMID: 24909690 DOI: 10.1016/j.bbrc.2014.05.115] [Cited by in Crossref: 107] [Cited by in F6Publishing: 105] [Article Influence: 13.4] [Reference Citation Analysis]
98 Plava J, Cihova M, Burikova M, Bohac M, Adamkov M, Drahosova S, Rusnakova D, Pindak D, Karaba M, Simo J, Mego M, Danisovic L, Kucerova L, Miklikova S. Permanent Pro-Tumorigenic Shift in Adipose Tissue-Derived Mesenchymal Stromal Cells Induced by Breast Malignancy. Cells 2020;9:E480. [PMID: 32093026 DOI: 10.3390/cells9020480] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
99 Park YH, Kim SJ, Jeong BH, Herzog TJ, Wright J, Kitajewski J, Rhim CC, Jang PR, Kang JB, Kim SJ. Follicular stimulating hormone enhances Notch 1 expression in SK-OV-3 ovarian cancer cells. J Gynecol Oncol 2010;21:119-24. [PMID: 20613903 DOI: 10.3802/jgo.2010.21.2.119] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
100 Nowell CS, Radtke F. Notch as a tumour suppressor. Nat Rev Cancer 2017;17:145-59. [PMID: 28154375 DOI: 10.1038/nrc.2016.145] [Cited by in Crossref: 173] [Cited by in F6Publishing: 163] [Article Influence: 34.6] [Reference Citation Analysis]
101 Sethi N, Kang Y. Notch signalling in cancer progression and bone metastasis. Br J Cancer 2011;105:1805-10. [PMID: 22075946 DOI: 10.1038/bjc.2011.497] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 5.5] [Reference Citation Analysis]
102 Groth C, Fortini ME. Therapeutic approaches to modulating Notch signaling: current challenges and future prospects. Semin Cell Dev Biol 2012;23:465-72. [PMID: 22309842 DOI: 10.1016/j.semcdb.2012.01.016] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 8.6] [Reference Citation Analysis]
103 Baker A, Wyatt D, Bocchetta M, Li J, Filipovic A, Green A, Peiffer DS, Fuqua S, Miele L, Albain KS, Osipo C. Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival. Oncogene 2018;37:4489-504. [PMID: 29743588 DOI: 10.1038/s41388-018-0251-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
104 Adega F, Borges A, Chaves R. Cat Mammary Tumors: Genetic Models for the Human Counterpart. Vet Sci 2016;3:E17. [PMID: 29056725 DOI: 10.3390/vetsci3030017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
105 Aste-Amézaga M, Zhang N, Lineberger JE, Arnold BA, Toner TJ, Gu M, Huang L, Vitelli S, Vo KT, Haytko P, Zhao JZ, Baleydier F, L'Heureux S, Wang H, Gordon WR, Thoryk E, Andrawes MB, Tiyanont K, Stegmaier K, Roti G, Ross KN, Franlin LL, Wang H, Wang F, Chastain M, Bett AJ, Audoly LP, Aster JC, Blacklow SC, Huber HE. Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors. PLoS One 2010;5:e9094. [PMID: 20161710 DOI: 10.1371/journal.pone.0009094] [Cited by in Crossref: 127] [Cited by in F6Publishing: 114] [Article Influence: 10.6] [Reference Citation Analysis]
106 González-González A, González A, Rueda N, Alonso-González C, Menéndez JM, Martínez-Campa C, Mitola S, Cos S. Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process. Sci Rep 2020;10:4790. [PMID: 32179814 DOI: 10.1038/s41598-020-61622-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
107 Yuan X, Zhang M, Wu H, Xu H, Han N, Chu Q, Yu S, Chen Y, Wu K. Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis. PLoS One 2015;10:e0131689. [PMID: 26121683 DOI: 10.1371/journal.pone.0131689] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
108 Santilli G, Binda M, Zaffaroni N, Daidone MG. Breast cancer-initiating cells: insights into novel treatment strategies. Cancers (Basel) 2011;3:1405-25. [PMID: 24212666 DOI: 10.3390/cancers3011405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
109 Egloff AM, Grandis JR. Molecular pathways: context-dependent approaches to Notch targeting as cancer therapy. Clin Cancer Res 2012;18:5188-95. [PMID: 22773520 DOI: 10.1158/1078-0432.CCR-11-2258] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
110 Arai MA, Akamine R, Tsuchiya A, Yoneyama T, Koyano T, Kowithayakorn T, Ishibashi M. The Notch inhibitor cowanin accelerates nicastrin degradation. Sci Rep 2018;8:5376. [PMID: 29599482 DOI: 10.1038/s41598-018-23698-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
111 Tang L, Gao Y, Song Y, Li Y, Li Y, Zhang H, Li D, Li J, Liu C, Li F. PAK4 phosphorylating RUNX1 promotes ERα-positive breast cancer-induced osteolytic bone destruction. Int J Biol Sci 2020;16:2235-47. [PMID: 32549768 DOI: 10.7150/ijbs.47225] [Reference Citation Analysis]
112 Liu L, Zhang L, Zhao S, Zhao XY, Min PX, Ma YD, Wang YY, Chen Y, Tang SJ, Zhang YJ, Du J, Gu L. Non-canonical Notch Signaling Regulates Actin Remodeling in Cell Migration by Activating PI3K/AKT/Cdc42 Pathway. Front Pharmacol 2019;10:370. [PMID: 31057403 DOI: 10.3389/fphar.2019.00370] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
113 Xu F, Zhang ZQ, Fang YC, Li XL, Sun Y, Xiong CZ, Yan LQ, Wang Q. Metastasis-associated lung adenocarcinoma transcript 1 promotes the proliferation of chondrosarcoma cell via activating Notch-1 signaling pathway. Onco Targets Ther 2016;9:2143-51. [PMID: 27110130 DOI: 10.2147/OTT.S100003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
114 Firestone AJ, Chen JK. Controlling destiny through chemistry: small-molecule regulators of cell fate. ACS Chem Biol 2010;5:15-34. [PMID: 20000447 DOI: 10.1021/cb900249y] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
115 González-González A, González A, Rueda N, Alonso-González C, Menéndez-Menéndez J, Gómez-Arozamena J, Martínez-Campa C, Cos S. Melatonin Enhances the Usefulness of Ionizing Radiation: Involving the Regulation of Different Steps of the Angiogenic Process. Front Physiol 2019;10:879. [PMID: 31354524 DOI: 10.3389/fphys.2019.00879] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
116 Cao YW, Li WQ, Wan GX, Li YX, Du XM, Li YC, Li F. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer. J Exp Clin Cancer Res 2014;33:97. [PMID: 25420528 DOI: 10.1186/s13046-014-0097-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
117 Guenter R, Patel Z, Chen H. Notch Signaling in Thyroid Cancer. Adv Exp Med Biol 2021;1287:155-68. [PMID: 33034031 DOI: 10.1007/978-3-030-55031-8_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
118 Sui C, Zhuang C, Sun D, Yang L, Zhang L, Song L. Notch1 regulates the JNK signaling pathway and increases apoptosis in hepatocellular carcinoma. Oncotarget 2017;8:45837-47. [PMID: 28507277 DOI: 10.18632/oncotarget.17434] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
119 Sardesai S, Badawi M, Mrozek E, Morgan E, Phelps M, Stephens J, Wei L, Kassem M, Ling Y, Lustberg M, Stover D, Williams N, Layman R, Reinbolt R, VanDeusen J, Cherian M, Grever M, Carson W, Ramaswamy B, Wesolowski R. A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer. Invest New Drugs 2020;38:1400-10. [PMID: 31953695 DOI: 10.1007/s10637-020-00895-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
120 Pamarthy S, Jaiswal MK, Kulshreshtha A, Katara GK, Gilman-Sachs A, Beaman KD. The Vacuolar ATPase a2-subunit regulates Notch signaling in triple-negative breast cancer cells. Oncotarget 2015;6:34206-20. [PMID: 26418877 DOI: 10.18632/oncotarget.5275] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
121 Brennan K, Clarke RB. Combining Notch inhibition with current therapies for breast cancer treatment. Ther Adv Med Oncol 2013;5:17-24. [PMID: 23323144 DOI: 10.1177/1758834012457437] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
122 Leong KG, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I, Karsan A. Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med 2007;204:2935-48. [PMID: 17984306 DOI: 10.1084/jem.20071082] [Cited by in Crossref: 321] [Cited by in F6Publishing: 303] [Article Influence: 21.4] [Reference Citation Analysis]
123 Ingthorsson S, Briem E, Bergthorsson JT, Gudjonsson T. Epithelial Plasticity During Human Breast Morphogenesis and Cancer Progression. J Mammary Gland Biol Neoplasia 2016;21:139-48. [PMID: 27815674 DOI: 10.1007/s10911-016-9366-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
124 Liubomirski Y, Ben-Baruch A. Notch-Inflammation Networks in Regulation of Breast Cancer Progression. Cells 2020;9:E1576. [PMID: 32605277 DOI: 10.3390/cells9071576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
125 LoConte NK, Razak AR, Ivy P, Tevaarwerk A, Leverence R, Kolesar J, Siu L, Lubner SJ, Mulkerin DL, Schelman WR, Deming DA, Holen KD, Carmichael L, Eickhoff J, Liu G. A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors. Invest New Drugs 2015;33:169-76. [PMID: 25318436 DOI: 10.1007/s10637-014-0166-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
126 Zhang Z, Wang H, Ikeda S, Fahey F, Bielenberg D, Smits P, Hauschka PV. Notch3 in human breast cancer cell lines regulates osteoblast-cancer cell interactions and osteolytic bone metastasis. Am J Pathol 2010;177:1459-69. [PMID: 20651241 DOI: 10.2353/ajpath.2010.090476] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
127 Kim YS, Farrar W, Colburn NH, Milner JA. Cancer stem cells: potential target for bioactive food components. J Nutr Biochem 2012;23:691-8. [PMID: 22704055 DOI: 10.1016/j.jnutbio.2012.03.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
128 Hynes NE, Stoelzle T. Key signalling nodes in mammary gland development and cancer: Myc. Breast Cancer Res. 2009;11:210. [PMID: 19849814 DOI: 10.1186/bcr2406] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
129 Ishiguro H, Okubo T, Kuwabara Y, Kimura M, Mitsui A, Sugito N, Ogawa R, Katada T, Tanaka T, Shiozaki M, Mizoguchi K, Samoto Y, Matsuo Y, Takahashi H, Takiguchi S. NOTCH1 activates the Wnt/β-catenin signaling pathway in colon cancer. Oncotarget 2017;8:60378-89. [PMID: 28947978 DOI: 10.18632/oncotarget.19534] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
130 So JY, Wahler J, Das Gupta S, Salerno DM, Maehr H, Uskokovic M, Suh N. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer. J Steroid Biochem Mol Biol 2015;148:111-21. [PMID: 25541438 DOI: 10.1016/j.jsbmb.2014.12.013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
131 Smigiel JM, Taylor SE, Bryson BL, Tamagno I, Polak K, Jackson MW. Cellular plasticity and metastasis in breast cancer: a pre- and post-malignant problem. J Cancer Metastasis Treat 2019;5:47. [PMID: 32355893 DOI: 10.20517/2394-4722.2019.26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
132 Rasul S, Balasubramanian R, Filipović A, Slade MJ, Yagüe E, Coombes RC. Inhibition of gamma-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells. Br J Cancer 2009;100:1879-88. [PMID: 19513078 DOI: 10.1038/sj.bjc.6605034] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 5.0] [Reference Citation Analysis]
133 Zhang F, Ren C, Lau KK, Zheng Z, Lu G, Yi Z, Zhao Y, Su F, Zhang S, Zhang B, Sobie EA, Zhang W, Walsh MJ. A network medicine approach to build a comprehensive atlas for the prognosis of human cancer. Brief Bioinform 2016;17:1044-59. [PMID: 27559151 DOI: 10.1093/bib/bbw076] [Cited by in Crossref: 9] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
134 BeLow M, Osipo C. Notch Signaling in Breast Cancer: A Role in Drug Resistance. Cells 2020;9:E2204. [PMID: 33003540 DOI: 10.3390/cells9102204] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
135 Raafat A, Goldhar AS, Klauzinska M, Xu K, Amirjazil I, McCurdy D, Lashin K, Salomon D, Vonderhaar BK, Egan S, Callahan R. Expression of Notch receptors, ligands, and target genes during development of the mouse mammary gland. J Cell Physiol 2011;226:1940-52. [PMID: 21506125 DOI: 10.1002/jcp.22526] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
136 Rizzo P, Miao H, D’Souza G, Osipo C, Song LL, Yun J, Zhao H, Mascarenhas J, Wyatt D, Antico G. Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res. 2008;68:5226-5235. [PMID: 18593923 DOI: 10.1158/0008-5472.can-07-5744] [Cited by in Crossref: 242] [Cited by in F6Publishing: 145] [Article Influence: 17.3] [Reference Citation Analysis]
137 Sethi N, Dai X, Winter CG, Kang Y. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell. 2011;19:192-205. [PMID: 21295524 DOI: 10.1016/j.ccr.2010.12.022] [Cited by in Crossref: 383] [Cited by in F6Publishing: 341] [Article Influence: 34.8] [Reference Citation Analysis]
138 Ho AS, Kannan K, Roy DM, Morris LG, Ganly I, Katabi N, Ramaswami D, Walsh LA, Eng S, Huse JT, Zhang J, Dolgalev I, Huberman K, Heguy A, Viale A, Drobnjak M, Leversha MA, Rice CE, Singh B, Iyer NG, Leemans CR, Bloemena E, Ferris RL, Seethala RR, Gross BE, Liang Y, Sinha R, Peng L, Raphael BJ, Turcan S, Gong Y, Schultz N, Kim S, Chiosea S, Shah JP, Sander C, Lee W, Chan TA. The mutational landscape of adenoid cystic carcinoma. Nat Genet 2013;45:791-8. [PMID: 23685749 DOI: 10.1038/ng.2643] [Cited by in Crossref: 271] [Cited by in F6Publishing: 245] [Article Influence: 30.1] [Reference Citation Analysis]
139 Garcia A, Kandel JJ. Notch: a key regulator of tumor angiogenesis and metastasis. Histol Histopathol 2012;27:151-6. [PMID: 22207549 DOI: 10.14670/HH-27.151] [Cited by in F6Publishing: 27] [Reference Citation Analysis]
140 Ercan C, van Diest PJ, Vooijs M. Mammary development and breast cancer: the role of stem cells. Curr Mol Med. 2011;11:270-285. [PMID: 21506923 DOI: 10.2174/156652411795678007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
141 Feng Z, Xu W, Zhang C, Liu M, Wen H. Inhibition of gamma-secretase in Notch1 signaling pathway as a novel treatment for ovarian cancer. Oncotarget 2017;8:8215-25. [PMID: 28030808 DOI: 10.18632/oncotarget.14152] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
142 Strosberg JR, Yeatman T, Weber J, Coppola D, Schell MJ, Han G, Almhanna K, Kim R, Valone T, Jump H, Sullivan D. A phase II study of RO4929097 in metastatic colorectal cancer. Eur J Cancer. 2012;48:997-1003. [PMID: 22445247 DOI: 10.1016/j.ejca.2012.02.056] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 8.5] [Reference Citation Analysis]
143 Pignatelli J, Bravo-Cordero JJ, Roh-Johnson M, Gandhi SJ, Wang Y, Chen X, Eddy RJ, Xue A, Singer RH, Hodgson L, Oktay MH, Condeelis JS. Macrophage-dependent tumor cell transendothelial migration is mediated by Notch1/MenaINV-initiated invadopodium formation. Sci Rep 2016;6:37874. [PMID: 27901093 DOI: 10.1038/srep37874] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 8.2] [Reference Citation Analysis]
144 Zhao F, Pu Y, Qian L, Zang C, Tao Z, Gao J. MiR-20a-5p promotes radio-resistance by targeting NPAS2 in nasopharyngeal cancer cells. Oncotarget 2017;8:105873-81. [PMID: 29285299 DOI: 10.18632/oncotarget.22411] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
145 Ma Y, Fan B, Ren Z, Liu B, Wang Y. Long noncoding RNA DANCR contributes to docetaxel resistance in prostate cancer through targeting the miR-34a-5p/JAG1 pathway. Onco Targets Ther 2019;12:5485-97. [PMID: 31371987 DOI: 10.2147/OTT.S197009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 8.3] [Reference Citation Analysis]
146 Edwards A, Brennan K. Notch Signalling in Breast Development and Cancer. Front Cell Dev Biol 2021;9:692173. [PMID: 34295896 DOI: 10.3389/fcell.2021.692173] [Reference Citation Analysis]
147 LaBarge MA, Nelson CM, Villadsen R, Fridriksdottir A, Ruth JR, Stampfer MR, Petersen OW, Bissell MJ. Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenvironments. Integr Biol (Camb) 2009;1:70-9. [PMID: 20023793 DOI: 10.1039/b816472j] [Cited by in Crossref: 133] [Cited by in F6Publishing: 85] [Article Influence: 9.5] [Reference Citation Analysis]
148 Grochowski CM, Loomes KM, Spinner NB. Jagged1 (JAG1): Structure, expression, and disease associations. Gene 2016;576:381-4. [PMID: 26548814 DOI: 10.1016/j.gene.2015.10.065] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 8.6] [Reference Citation Analysis]
149 Carvalho FL, Simons BW, Eberhart CG, Berman DM. Notch signaling in prostate cancer: a moving target. Prostate 2014;74:933-45. [PMID: 24737393 DOI: 10.1002/pros.22811] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
150 Santio NM, Landor SK, Vahtera L, Ylä-Pelto J, Paloniemi E, Imanishi SY, Corthals G, Varjosalo M, Manoharan GB, Uri A, Lendahl U, Sahlgren C, Koskinen PJ. Phosphorylation of Notch1 by Pim kinases promotes oncogenic signaling in breast and prostate cancer cells. Oncotarget 2016;7:43220-38. [PMID: 27281612 DOI: 10.18632/oncotarget.9215] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
151 Li D, Masiero M, Banham AH, Harris AL. The notch ligand JAGGED1 as a target for anti-tumor therapy. Front Oncol 2014;4:254. [PMID: 25309874 DOI: 10.3389/fonc.2014.00254] [Cited by in Crossref: 98] [Cited by in F6Publishing: 94] [Article Influence: 12.3] [Reference Citation Analysis]
152 Kontomanolis EN, Kalagasidou S, Pouliliou S, Anthoulaki X, Georgiou N, Papamanolis V, Fasoulakis ZN. The Notch Pathway in Breast Cancer Progression. ScientificWorldJournal 2018;2018:2415489. [PMID: 30111989 DOI: 10.1155/2018/2415489] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
153 Shao S, Zhao X, Zhang X, Luo M, Zuo X, Huang S, Wang Y, Gu S, Zhao X. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Mol Cancer 2015;14:28. [PMID: 25645291 DOI: 10.1186/s12943-015-0295-3] [Cited by in Crossref: 105] [Cited by in F6Publishing: 103] [Article Influence: 15.0] [Reference Citation Analysis]
154 Bolós V, Mira E, Martínez-Poveda B, Luxán G, Cañamero M, Martínez-A C, Mañes S, de la Pompa JL. Notch activation stimulates migration of breast cancer cells and promotes tumor growth. Breast Cancer Res 2013;15:R54. [PMID: 23826634 DOI: 10.1186/bcr3447] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 10.0] [Reference Citation Analysis]
155 Jin MM, Ye YZ, Qian ZD, Zhang YB. Notch signaling molecules as prognostic biomarkers for non-small cell lung cancer. Oncol Lett 2015;10:3252-60. [PMID: 26722321 DOI: 10.3892/ol.2015.3662] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
156 De Francesco EM, Maggiolini M, Musti AM. Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT. Int J Mol Sci 2018;19:E2011. [PMID: 29996493 DOI: 10.3390/ijms19072011] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 11.8] [Reference Citation Analysis]
157 Lee J, Sehrawat A, Singh SV. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells. Breast Cancer Res Treat 2012;136:45-56. [PMID: 22965833 DOI: 10.1007/s10549-012-2239-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
158 Jevitt A, Huang YC, Zhang SM, Chatterjee D, Wang XF, Xie GQ, Deng WM. Modeling Notch-Induced Tumor Cell Survival in the Drosophila Ovary Identifies Cellular and Transcriptional Response to Nuclear NICD Accumulation. Cells 2021;10:2222. [PMID: 34571871 DOI: 10.3390/cells10092222] [Reference Citation Analysis]
159 Yadav AK, Desai NS. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects. Stem Cell Rev Rep 2019;15:331-55. [PMID: 30993589 DOI: 10.1007/s12015-019-09887-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 19.0] [Reference Citation Analysis]
160 Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, Bundred NJ, Clarke RB. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res 2010;70:709-18. [PMID: 20068161 DOI: 10.1158/0008-5472.CAN-09-1681] [Cited by in Crossref: 342] [Cited by in F6Publishing: 238] [Article Influence: 28.5] [Reference Citation Analysis]
161 Ayyanan A, Civenni G, Ciarloni L, Morel C, Mueller N, Lefort K, Mandinova A, Raffoul W, Fiche M, Dotto GP, Brisken C. Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc Natl Acad Sci U S A 2006;103:3799-804. [PMID: 16501043 DOI: 10.1073/pnas.0600065103] [Cited by in Crossref: 199] [Cited by in F6Publishing: 193] [Article Influence: 12.4] [Reference Citation Analysis]
162 Lan L, Holland JD, Qi J, Grosskopf S, Rademann J, Vogel R, Györffy B, Wulf-Goldenberg A, Birchmeier W. Shp2 signaling suppresses senescence in PyMT-induced mammary gland cancer in mice. EMBO J 2015;34:1493-508. [PMID: 25736378 DOI: 10.15252/embj.201489004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
163 He W, Chan CM, Wong SC, Au TC, Ho WS, Chan AK, Chan AS, Ma BB, Chan AT. Jagged 2 silencing inhibits motility and invasiveness of colorectal cancer cell lines. Oncol Lett 2016;12:5193-8. [PMID: 28105228 DOI: 10.3892/ol.2016.5321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
164 Sahebjam S, Bedard PL, Castonguay V, Chen Z, Reedijk M, Liu G, Cohen B, Zhang WJ, Clarke B, Zhang T, Kamel-Reid S, Chen H, Ivy SP, Razak AR, Oza AM, Chen EX, Hirte HW, McGarrity A, Wang L, Siu LL, Hotte SJ. A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503). Br J Cancer 2013;109:943-9. [PMID: 23868004 DOI: 10.1038/bjc.2013.380] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
165 Han J, Ma I, Hendzel MJ, Allalunis-Turner J. The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition. Breast Cancer Res. 2009;11:R57. [PMID: 19660128 DOI: 10.1186/bcr2347] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 4.0] [Reference Citation Analysis]
166 Simon EP, Freije CA, Farber BA, Lalazar G, Darcy DG, Honeyman JN, Chiaroni-Clarke R, Dill BD, Molina H, Bhanot UK, La Quaglia MP, Rosenberg BR, Simon SM. Transcriptomic characterization of fibrolamellar hepatocellular carcinoma. Proc Natl Acad Sci U S A 2015;112:E5916-25. [PMID: 26489647 DOI: 10.1073/pnas.1424894112] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 9.0] [Reference Citation Analysis]
167 Wang Z, Li Y, Ahmad A, Azmi AS, Banerjee S, Kong D, Sarkar FH. Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochim Biophys Acta. 2010;1806:258-267. [PMID: 20600632 DOI: 10.1016/j.bbcan.2010.06.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 102] [Article Influence: 3.7] [Reference Citation Analysis]
168 Wu JK, Kitajewski JK. A potential role for notch signaling in the pathogenesis and regulation of hemangiomas. J Craniofac Surg 2009;20 Suppl 1:698-702. [PMID: 19169152 DOI: 10.1097/SCS.0b013e318193d898] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
169 Shah D, Wyatt D, Baker AT, Simms P, Peiffer DS, Fernandez M, Rakha E, Green A, Filipovic A, Miele L, Osipo C. Inhibition of HER2 Increases JAGGED1-dependent Breast Cancer Stem Cells: Role for Membrane JAGGED1. Clin Cancer Res 2018;24:4566-78. [PMID: 29895705 DOI: 10.1158/1078-0432.CCR-17-1952] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
170 Han N, Hu G, Shi L, Long G, Yang L, Xi Q, Guo Q, Wang J, Dong Z, Zhang M. Notch1 ablation radiosensitizes glioblastoma cells. Oncotarget 2017;8:88059-68. [PMID: 29152141 DOI: 10.18632/oncotarget.21409] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
171 Shin S, Kim K, Kim HR, Ylaya K, Do SI, Hewitt SM, Park HS, Roe JS, Chung JY, Song J. Deubiquitylation and stabilization of Notch1 intracellular domain by ubiquitin-specific protease 8 enhance tumorigenesis in breast cancer. Cell Death Differ 2020;27:1341-54. [PMID: 31527799 DOI: 10.1038/s41418-019-0419-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
172 Acar A, Simões BM, Clarke RB, Brennan K. A Role for Notch Signalling in Breast Cancer and Endocrine Resistance. Stem Cells Int 2016;2016:2498764. [PMID: 26880941 DOI: 10.1155/2016/2498764] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
173 Sun J, Wang X, Xu RG, Mao D, Shen D, Wang X, Qiu Y, Han Y, Lu X, Li Y, Che Q, Zheng L, Peng P, Kang X, Zhu R, Jia Y, Wang Y, Liu LP, Chang Z, Ji JY, Wang Z, Liu Q, Li S, Sun FL, Ni JQ. HP1c regulates development and gut homeostasis by suppressing Notch signaling through Su(H). EMBO Rep 2021;22:e51298. [PMID: 33594776 DOI: 10.15252/embr.202051298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 Johansson E, Rönö B, Johansson M, Lindgren D, Möller C, Axelson H, Smith EM. Simultaneous targeted activation of Notch1 and Vhl-disruption in the kidney proximal epithelial tubular cells in mice. Sci Rep 2016;6:30739. [PMID: 27491826 DOI: 10.1038/srep30739] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
175 Wang Z, Li Y, Sarkar FH. Notch signaling proteins: legitimate targets for cancer therapy. Curr Protein Pept Sci 2010;11:398-408. [PMID: 20491628 DOI: 10.2174/138920310791824039] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
176 Choi S, Yu J, Park A, Dubon MJ, Do J, Kim Y, Nam D, Noh J, Park KS. BMP-4 enhances epithelial mesenchymal transition and cancer stem cell properties of breast cancer cells via Notch signaling. Sci Rep 2019;9:11724. [PMID: 31409851 DOI: 10.1038/s41598-019-48190-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
177 Chang WH, Ho BC, Hsiao YJ, Chen JS, Yeh CH, Chen HY, Chang GC, Su KY, Yu SL. JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer. PLoS One 2016;11:e0150355. [PMID: 26930648 DOI: 10.1371/journal.pone.0150355] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
178 Li J, Qu W, Jiang Y, Sun Y, Cheng Y, Zou T, Du S. miR-489 Suppresses Proliferation and Invasion of Human Bladder Cancer Cells. Oncol Res 2016;24:391-8. [PMID: 28281959 DOI: 10.3727/096504016X14666990347518] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
179 Hu C, Diévart A, Lupien M, Calvo E, Tremblay G, Jolicoeur P. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors. Am J Pathol 2006;168:973-90. [PMID: 16507912 DOI: 10.2353/ajpath.2006.050416] [Cited by in Crossref: 124] [Cited by in F6Publishing: 123] [Article Influence: 7.8] [Reference Citation Analysis]
180 Mutvei AP, Fredlund E, Lendahl U. Frequency and distribution of Notch mutations in tumor cell lines. BMC Cancer 2015;15:311. [PMID: 25907971 DOI: 10.1186/s12885-015-1278-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
181 Guo S, Liu M, Gonzalez-Perez RR. Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta. 2011;1815:197-213. [PMID: 21193018 DOI: 10.1016/j.bbcan.2010.12.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 116] [Article Influence: 3.9] [Reference Citation Analysis]
182 Sun D, Ma T, Zhang Y, Zhang F, Cui B. Overexpressed miR-335-5p reduces atherosclerotic vulnerable plaque formation in acute coronary syndrome. J Clin Lab Anal 2021;35:e23608. [PMID: 33277957 DOI: 10.1002/jcla.23608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
183 Chung CY, Sun Z, Mullokandov G, Bosch A, Qadeer ZA, Cihan E, Rapp Z, Parsons R, Aguirre-Ghiso JA, Farias EF. Cbx8 Acts Non-canonically with Wdr5 to Promote Mammary Tumorigenesis. Cell Rep. 2016;16:472-486. [PMID: 27346354 DOI: 10.1016/j.celrep.2016.06.002] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 8.8] [Reference Citation Analysis]
184 Baker AT, Zlobin A, Osipo C. Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer. Front Oncol 2014;4:360. [PMID: 25566499 DOI: 10.3389/fonc.2014.00360] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
185 Gao Y, Yang M, Wei L, Liang X, Wu F, Huang Y, Yang T. miR-34a-5p Inhibits Cell Proliferation, Migration and Invasion Through Targeting JAG1/Notch1 Pathway in HPV-Infected Human Epidermal Keratinocytes. Pathol Oncol Res 2020;26:1851-9. [PMID: 31781973 DOI: 10.1007/s12253-019-00782-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
186 Fukusumi T, Califano JA. The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma. J Dent Res 2018;97:645-53. [PMID: 29489439 DOI: 10.1177/0022034518760297] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
187 Nandi A, Chakrabarti R. The many facets of Notch signaling in breast cancer: toward overcoming therapeutic resistance. Genes Dev 2020;34:1422-38. [PMID: 33872192 DOI: 10.1101/gad.342287.120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
188 Han J, Hendzel MJ, Allalunis-Turner J. Notch signaling as a therapeutic target for breast cancer treatment? Breast Cancer Res 2011;13:210. [PMID: 21672271 DOI: 10.1186/bcr2875] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
189 Clementz AG, Osipo C. Notch versus the proteasome: what is the target of gamma-secretase inhibitor-I? Breast Cancer Res 2009;11:110. [PMID: 19849815 DOI: 10.1186/bcr2407] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
190 Li X, Wang M, Li S, Chen Y, Wang M, Wu Z, Sun X, Yao L, Dong H, Song Y, Xu Y. HIF-1-induced mitochondrial ribosome protein L52: a mechanism for breast cancer cellular adaptation and metastatic initiation in response to hypoxia. Theranostics 2021;11:7337-59. [PMID: 34158854 DOI: 10.7150/thno.57804] [Reference Citation Analysis]
191 Chen J, Imanaka N, Chen J, Griffin JD. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br J Cancer. 2010;102:351-360. [PMID: 20010940 DOI: 10.1038/sj.bjc.6605486] [Cited by in Crossref: 215] [Cited by in F6Publishing: 211] [Article Influence: 16.5] [Reference Citation Analysis]
192 Peltonen HM, Haapasalo A, Hiltunen M, Kataja V, Kosma VM, Mannermaa A. Γ-secretase components as predictors of breast cancer outcome. PLoS One 2013;8:e79249. [PMID: 24223915 DOI: 10.1371/journal.pone.0079249] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
193 Wu Y, Sarkissyan M, Vadgama JV. Epithelial-Mesenchymal Transition and Breast Cancer. J Clin Med 2016;5:E13. [PMID: 26821054 DOI: 10.3390/jcm5020013] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 17.2] [Reference Citation Analysis]
194 Xu K, Usary J, Kousis PC, Prat A, Wang DY, Adams JR, Wang W, Loch AJ, Deng T, Zhao W, Cardiff RD, Yoon K, Gaiano N, Ling V, Beyene J, Zacksenhaus E, Gridley T, Leong WL, Guidos CJ, Perou CM, Egan SE. Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer. Cancer Cell 2012;21:626-41. [PMID: 22624713 DOI: 10.1016/j.ccr.2012.03.041] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 8.1] [Reference Citation Analysis]
195 Altieri DC. New wirings in the survivin networks. Oncogene 2008;27:6276-84. [PMID: 18931693 DOI: 10.1038/onc.2008.303] [Cited by in Crossref: 121] [Cited by in F6Publishing: 126] [Article Influence: 8.6] [Reference Citation Analysis]
196 Sehrawat A, Sakao K, Singh SV. Notch2 activation is protective against anticancer effects of zerumbone in human breast cancer cells. Breast Cancer Res Treat 2014;146:543-55. [PMID: 25038880 DOI: 10.1007/s10549-014-3059-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
197 Du X, Zhao YP, Zhang TP, Zhou L, Chen G, Cui QC, Shi J, Wang TX, You L, Shu H. Notch1 contributes to chemoresistance to gemcitabine and serves as an unfavorable prognostic indicator in pancreatic cancer. World J Surg 2013;37:1688-94. [PMID: 23568245 DOI: 10.1007/s00268-013-2010-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
198 Konishi J, Yi F, Chen X, Vo H, Carbone DP, Dang TP. Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim. Oncogene 2010;29:589-96. [PMID: 19881544 DOI: 10.1038/onc.2009.366] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 4.6] [Reference Citation Analysis]
199 Izrailit J, Jaiswal A, Zheng W, Moran MF, Reedijk M. Cellular stress induces TRB3/USP9x-dependent Notch activation in cancer. Oncogene 2017;36:1048-57. [PMID: 27593927 DOI: 10.1038/onc.2016.276] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
200 Borah A, Raveendran S, Rochani A, Maekawa T, Kumar DS. Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy. Oncogenesis 2015;4:e177. [PMID: 26619402 DOI: 10.1038/oncsis.2015.35] [Cited by in Crossref: 95] [Cited by in F6Publishing: 92] [Article Influence: 13.6] [Reference Citation Analysis]
201 Cui Y, Li Q, Li W, Wang Y, Lv F, Shi X, Tang Z, Shen Z, Hou Y, Zhang H, Mao B, Liu T. NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric Cancer. Front Oncol 2020;10:574937. [PMID: 33479597 DOI: 10.3389/fonc.2020.574937] [Reference Citation Analysis]
202 Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer. 2011;11:338-351. [PMID: 21508972 DOI: 10.1038/nrc3035] [Cited by in Crossref: 523] [Cited by in F6Publishing: 496] [Article Influence: 47.5] [Reference Citation Analysis]
203 Sales-Dias J, Silva G, Lamy M, Ferreira A, Barbas A. The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells. PLoS One 2019;14:e0217002. [PMID: 31107884 DOI: 10.1371/journal.pone.0217002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
204 Sharma VP, Tang B, Wang Y, Duran CL, Karagiannis GS, Xue EA, Entenberg D, Borriello L, Coste A, Eddy RJ, Kim G, Ye X, Jones JG, Grunblatt E, Agi N, Roy S, Bandyopadhyaya G, Adler E, Surve CR, Esposito D, Goswami S, Segall JE, Guo W, Condeelis JS, Wakefield LM, Oktay MH. Live tumor imaging shows macrophage induction and TMEM-mediated enrichment of cancer stem cells during metastatic dissemination. Nat Commun 2021;12:7300. [PMID: 34911937 DOI: 10.1038/s41467-021-27308-2] [Reference Citation Analysis]
205 Ayaz F, Osborne BA. Non-canonical notch signaling in cancer and immunity. Front Oncol 2014;4:345. [PMID: 25538890 DOI: 10.3389/fonc.2014.00345] [Cited by in Crossref: 87] [Cited by in F6Publishing: 80] [Article Influence: 10.9] [Reference Citation Analysis]
206 Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M, Ceccarelli C, Santini D, Paterini P, Marcu KB. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest. 2007;117:3988-4002. [PMID: 18060036 DOI: 10.1172/jci32533] [Cited by in Crossref: 566] [Cited by in F6Publishing: 331] [Article Influence: 40.4] [Reference Citation Analysis]
207 Chen JY, Li CF, Chu PY, Lai YS, Chen CH, Jiang SS, Hou MF, Hung WC. Lysine demethylase 2A promotes stemness and angiogenesis of breast cancer by upregulating Jagged1. Oncotarget 2016;7:27689-710. [PMID: 27029061 DOI: 10.18632/oncotarget.8381] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
208 Mori M, Miyamoto T, Yakushiji H, Ohno S, Miyake Y, Sakaguchi T, Hattori M, Hongo A, Nakaizumi A, Ueda M, Ohno E. Effects of N-[N-(3, 5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT) on cell proliferation and apoptosis in Ishikawa endometrial cancer cells. Hum Cell 2012;25:9-15. [PMID: 22189483 DOI: 10.1007/s13577-011-0038-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
209 Trindade A, Duarte A. Notch Signaling Function in the Angiocrine Regulation of Tumor Development. Cells 2020;9:E2467. [PMID: 33198378 DOI: 10.3390/cells9112467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
210 Orzechowska M, Anusewicz D, Bednarek AK. Functional Gene Expression Differentiation of the Notch Signaling Pathway in Female Reproductive Tract Tissues-A Comprehensive Review With Analysis. Front Cell Dev Biol 2020;8:592616. [PMID: 33384996 DOI: 10.3389/fcell.2020.592616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
211 Lim KJ, Brandt WD, Heth JA, Muraszko KM, Fan X, Bar EE, Eberhart CG. Lateral inhibition of Notch signaling in neoplastic cells. Oncotarget 2015;6:1666-77. [PMID: 25557173 DOI: 10.18632/oncotarget.2762] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
212 Gentle ME, Rose A, Bugeon L, Dallman MJ. Noncanonical Notch signaling modulates cytokine responses of dendritic cells to inflammatory stimuli. J Immunol 2012;189:1274-84. [PMID: 22753939 DOI: 10.4049/jimmunol.1103102] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
213 Mollen EWJ, Ient J, Tjan-Heijnen VCG, Boersma LJ, Miele L, Smidt ML, Vooijs MAGG. Moving Breast Cancer Therapy up a Notch. Front Oncol 2018;8:518. [PMID: 30515368 DOI: 10.3389/fonc.2018.00518] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
214 Larson Gedman A, Chen Q, Kugel Desmoulin S, Ge Y, LaFiura K, Haska CL, Cherian C, Devidas M, Linda SB, Taub JW, Matherly LH. The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia 2009;23:1417-25. [PMID: 19340001 DOI: 10.1038/leu.2009.64] [Cited by in Crossref: 97] [Cited by in F6Publishing: 100] [Article Influence: 7.5] [Reference Citation Analysis]
215 Avila JL, Kissil JL. Notch signaling in pancreatic cancer: oncogene or tumor suppressor? Trends Mol Med. 2013;19:320-327. [PMID: 23545339 DOI: 10.1016/j.molmed.2013.03.003] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 8.0] [Reference Citation Analysis]
216 Sizemore GM, Balakrishnan S, Hammer AM, Thies KA, Trimboli AJ, Wallace JA, Sizemore ST, Kladney RD, Woelke SA, Yu L, Fernandez SA, Chakravarti A, Leone G, Ostrowski MC. Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1. Oncogene 2017;36:2297-308. [PMID: 27797378 DOI: 10.1038/onc.2016.383] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
217 Wang Z, Li Y, Kong D, Ahmad A, Banerjee S, Sarkar FH. Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. Cancer Lett 2010;292:141-8. [PMID: 20022691 DOI: 10.1016/j.canlet.2009.11.012] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 6.5] [Reference Citation Analysis]
218 Yoon HA, Noh MH, Kim BG, Han JS, Jang JS, Choi SR, Jeong JS, Chun JH. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma. World J Gastroenterol 2011; 17(35): 4023-4030 [PMID: 22046092 DOI: 10.3748/wjg.v17.i35.4023] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
219 Peng X, Pentassuglia L, Sawyer DB. Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern? Circ Res 2010;106:1022-34. [PMID: 20360265 DOI: 10.1161/CIRCRESAHA.109.211276] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
220 Kang L, Mao J, Tao Y, Song B, Ma W, Lu Y, Zhao L, Li J, Yang B, Li L. MicroRNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway. Cancer Sci 2015;106:700-8. [PMID: 25783790 DOI: 10.1111/cas.12656] [Cited by in Crossref: 83] [Cited by in F6Publishing: 82] [Article Influence: 11.9] [Reference Citation Analysis]
221 Lee M, Kim H, Kim E, Yi SY, Hwang SG, Yang S, Lim EK, Kim B, Jung J, Kang T. Multivalent Antibody-Nanoparticle Conjugates To Enhance the Sensitivity of Surface-Enhanced Raman Scattering-Based Immunoassays. ACS Appl Mater Interfaces 2018;10:37829-34. [PMID: 30360053 DOI: 10.1021/acsami.8b13180] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
222 Takebe N, Warren RQ, Ivy SP. Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. Breast Cancer Res 2011;13:211. [PMID: 21672282 DOI: 10.1186/bcr2876] [Cited by in Crossref: 123] [Cited by in F6Publishing: 125] [Article Influence: 11.2] [Reference Citation Analysis]
223 Zheng H, Bae Y, Kasimir-Bauer S, Tang R, Chen J, Ren G, Yuan M, Esposito M, Li W, Wei Y, Shen M, Zhang L, Tupitsyn N, Pantel K, King C, Sun J, Moriguchi J, Jun HT, Coxon A, Lee B, Kang Y. Therapeutic Antibody Targeting Tumor- and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy. Cancer Cell 2017;32:731-747.e6. [PMID: 29232552 DOI: 10.1016/j.ccell.2017.11.002] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 15.4] [Reference Citation Analysis]
224 Mazzone M, Selfors LM, Albeck J, Overholtzer M, Sale S, Carroll DL, Pandya D, Lu Y, Mills GB, Aster JC, Artavanis-Tsakonas S, Brugge JS. Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells. Proc Natl Acad Sci U S A 2010;107:5012-7. [PMID: 20194747 DOI: 10.1073/pnas.1000896107] [Cited by in Crossref: 111] [Cited by in F6Publishing: 116] [Article Influence: 9.3] [Reference Citation Analysis]
225 Bolós V, Blanco M, Medina V, Aparicio G, Díaz-Prado S, Grande E. Notch signalling in cancer stem cells. Clin Transl Oncol. 2009;11:11-19. [PMID: 19155199 DOI: 10.1007/s12094-009-0305-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 4.6] [Reference Citation Analysis]
226 Hicks C, Pannuti A, Miele L. Associating GWAS Information with the Notch Signaling Pathway Using Transcription Profiling. Cancer Inform 2011;10:93-108. [PMID: 21584266 DOI: 10.4137/CIN.S6072] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
227 Sun H, Li K, Shen S. A study of the role of Notch1 and JAG1 gene methylation in development of breast cancer. Med Oncol 2016;33:35. [PMID: 26971121 DOI: 10.1007/s12032-016-0750-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
228 Giuli MV, Giuliani E, Screpanti I, Bellavia D, Checquolo S. Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype. J Oncol 2019;2019:8707053. [PMID: 31379945 DOI: 10.1155/2019/8707053] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 13.3] [Reference Citation Analysis]
229 Ghiabi P, Jiang J, Pasquier J, Maleki M, Abu-Kaoud N, Rafii S, Rafii A. Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties. PLoS One 2014;9:e112424. [PMID: 25380486 DOI: 10.1371/journal.pone.0112424] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
230 Dai Y, Wilson G, Huang B, Peng M, Teng G, Zhang D, Zhang R, Ebert MP, Chen J, Wong BC, Chan KW, George J, Qiao L. Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer. Cell Death Dis 2014;5:e1170. [PMID: 24722295 DOI: 10.1038/cddis.2014.137] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 6.6] [Reference Citation Analysis]
231 Sakakibara-Konishi J, Ikezawa Y, Oizumi S, Kikuchi J, Kikuchi E, Mizugaki H, Kinoshita I, Dosaka-Akita H, Nishimura M. Combined antitumor effect of γ-secretase inhibitor and ABT-737 in Notch-expressing non-small cell lung cancer. Int J Clin Oncol 2017;22:257-68. [PMID: 27816990 DOI: 10.1007/s10147-016-1060-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
232 Raafat A, Bargo S, McCurdy D, Callahan R. The ANK repeats of Notch-4/Int3 activate NF-κB canonical pathway in the absence of Rbpj and causes mammary tumorigenesis. Sci Rep 2017;7:13690. [PMID: 29057904 DOI: 10.1038/s41598-017-13989-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
233 Hossain F, Sorrentino C, Ucar DA, Peng Y, Matossian M, Wyczechowska D, Crabtree J, Zabaleta J, Morello S, Del Valle L, Burow M, Collins-Burow B, Pannuti A, Minter LM, Golde TE, Osborne BA, Miele L. Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical Pathways. Front Oncol 2018;8:575. [PMID: 30564555 DOI: 10.3389/fonc.2018.00575] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
234 Mizugaki H, Sakakibara-Konishi J, Ikezawa Y, Kikuchi J, Kikuchi E, Oizumi S, Dang TP, Nishimura M. γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer. Br J Cancer 2012;106:1953-9. [PMID: 22596234 DOI: 10.1038/bjc.2012.178] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
235 Klinakis A, Szabolcs M, Politi K, Kiaris H, Artavanis-Tsakonas S, Efstratiadis A. Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice. Proc Natl Acad Sci USA. 2006;103:9262-9267. [PMID: 16751266 DOI: 10.1073/pnas.0603371103] [Cited by in Crossref: 151] [Cited by in F6Publishing: 146] [Article Influence: 9.4] [Reference Citation Analysis]
236 Séveno C, Loussouarn D, Bréchet S, Campone M, Juin P, Barillé-Nion S. γ-Secretase inhibition promotes cell death, Noxa upregulation, and sensitization to BH3 mimetic ABT-737 in human breast cancer cells. Breast Cancer Res 2012;14:R96. [PMID: 22703841 DOI: 10.1186/bcr3214] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
237 Farnie G, Clarke RB. Mammary stem cells and breast cancer--role of Notch signalling. Stem Cell Rev. 2007;3:169-175. [PMID: 17873349 DOI: 10.1007/s12015-007-0023-5] [Cited by in Crossref: 233] [Cited by in F6Publishing: 215] [Article Influence: 15.5] [Reference Citation Analysis]
238 Tu KS, Yao YM. Epithelial-mesenchymal transition and related signaling pathways in hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2016; 24(14): 2131-2142 [DOI: 10.11569/wcjd.v24.i14.2131] [Reference Citation Analysis]
239 Sugiyama M, Oki E, Nakaji Y, Tsutsumi S, Ono N, Nakanishi R, Sugiyama M, Nakashima Y, Sonoda H, Ohgaki K, Yamashita N, Saeki H, Okano S, Kitao H, Morita M, Oda Y, Maehara Y. High expression of the Notch ligand Jagged-1 is associated with poor prognosis after surgery for colorectal cancer. Cancer Sci. 2016;107:1705-1716. [PMID: 27589478 DOI: 10.1111/cas.13075] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
240 Li Y, Burns JA, Cheney CA, Zhang N, Vitelli S, Wang F, Bett A, Chastain M, Audoly LP, Zhang ZQ. Distinct expression profiles of Notch-1 protein in human solid tumors: Implications for development of targeted therapeutic monoclonal antibodies. Biologics 2010;4:163-71. [PMID: 20631820 DOI: 10.2147/btt.s11021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 0.1] [Reference Citation Analysis]
241 Lobry C, Oh P, Aifantis I. Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think. J Exp Med. 2011;208:1931-1935. [PMID: 21948802 DOI: 10.1084/jem.20111855] [Cited by in Crossref: 238] [Cited by in F6Publishing: 240] [Article Influence: 21.6] [Reference Citation Analysis]
242 Qiu XX, Wang CH, You N, Chen BJ, Wang XF, Chen YP, Lin ZX. High Jagged1 expression is associated with poor outcome in primary glioblastoma. Med Oncol 2015;32:341. [PMID: 25424769 DOI: 10.1007/s12032-014-0341-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
243 Yun J, Pannuti A, Espinoza I, Zhu H, Hicks C, Zhu X, Caskey M, Rizzo P, D'Souza G, Backus K, Denning MF, Coon J, Sun M, Bresnick EH, Osipo C, Wu J, Strack PR, Tonetti DA, Miele L. Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells. Oncogenesis 2013;2:e60. [PMID: 23917222 DOI: 10.1038/oncsis.2013.26] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
244 Li Q, Liu Q, Cheng W, Wei H, Jiang W, E F, Yu Y, Jin J, Zou C. Heme Oxygenase-1 Inhibits Tumor Metastasis Mediated by Notch1 Pathway in Murine Mammary Carcinoma. Oncol Res 2019;27:643-51. [PMID: 30764900 DOI: 10.3727/096504018X15415906335771] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
245 Pal D, Kolluru V, Chandrasekaran B, Baby BV, Aman M, Suman S, Sirimulla S, Sanders MA, Alatassi H, Ankem MK. Targeting aberrant expression of Notch-1 in ALDH+ cancer stem cells in breast cancer. Mol Carcinog. 2017;56:1127-1136. [PMID: 27753148 DOI: 10.1002/mc.22579] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
246 Brzozowa-Zasada M, Piecuch A, Dittfeld A, Mielańczyk Ł, Michalski M, Wyrobiec G, Harabin-Słowińska M, Kurek J, Wojnicz R. Notch signalling pathway as an oncogenic factor involved in cancer development. Contemp Oncol (Pozn) 2016;20:267-72. [PMID: 27688721 DOI: 10.5114/wo.2016.61845] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
247 Kulic I, Robertson G, Chang L, Baker JH, Lockwood WW, Mok W, Fuller M, Fournier M, Wong N, Chou V. Loss of the Notch effector RBPJ promotes tumorigenesis. J Exp Med. 2015;212:37-52. [PMID: 25512468 DOI: 10.1084/jem.20121192] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
248 Varghese E, Samuel SM, Abotaleb M, Cheema S, Mamtani R, Büsselberg D. The "Yin and Yang" of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers. Cancers (Basel) 2018;10:E346. [PMID: 30248941 DOI: 10.3390/cancers10100346] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
249 Zhang S, Chung WC, Miele L, Xu K. Targeting Met and Notch in the Lfng-deficient, Met-amplified triple-negative breast cancer. Cancer Biol Ther 2014;15:633-42. [PMID: 24556651 DOI: 10.4161/cbt.28180] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
250 Previs RA, Coleman RL, Harris AL, Sood AK. Molecular pathways: translational and therapeutic implications of the Notch signaling pathway in cancer. Clin Cancer Res. 2015;21:955-961. [PMID: 25388163 DOI: 10.1158/1078-0432.ccr-14-0809] [Cited by in Crossref: 87] [Cited by in F6Publishing: 57] [Article Influence: 10.9] [Reference Citation Analysis]
251 Arcaroli JJ, Powell RW, Varella-Garcia M, McManus M, Tan AC, Quackenbush KS, Pitts TM, Gao D, Spreafico A, Dasari A, Touban BM, Messersmith WA. ALDH+ tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ-secretase inhibitor and irinotecan in colorectal cancer. Mol Oncol 2012;6:370-81. [PMID: 22521243 DOI: 10.1016/j.molonc.2012.03.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
252 Groot AJ, Vooijs MA. The role of Adams in Notch signaling. Adv Exp Med Biol 2012;727:15-36. [PMID: 22399336 DOI: 10.1007/978-1-4614-0899-4_2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
253 Kasper M, Jaks V, Fiaschi M, Toftgård R. Hedgehog signalling in breast cancer. Carcinogenesis 2009;30:903-11. [PMID: 19237605 DOI: 10.1093/carcin/bgp048] [Cited by in Crossref: 93] [Cited by in F6Publishing: 87] [Article Influence: 7.2] [Reference Citation Analysis]
254 O'Neill CF, Urs S, Cinelli C, Lincoln A, Nadeau RJ, León R, Toher J, Mouta-Bellum C, Friesel RE, Liaw L. Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth. Am J Pathol. 2007;171:1023-1036. [PMID: 17675579 DOI: 10.2353/ajpath.2007.061029] [Cited by in Crossref: 83] [Cited by in F6Publishing: 81] [Article Influence: 5.5] [Reference Citation Analysis]
255 Zhang J, Sun W, Kong X, Zhang Y, Yang HJ, Ren C, Jiang Y, Chen M, Chen X. Mutant p53 antagonizes p63/p73-mediated tumor suppression via Notch1. Proc Natl Acad Sci U S A 2019;116:24259-67. [PMID: 31712410 DOI: 10.1073/pnas.1913919116] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
256 Wang Y, Lin Q, Song C, Ma R, Li X. Depletion of circ_0007841 inhibits multiple myeloma development and BTZ resistance via miR-129-5p/JAG1 axis. Cell Cycle 2020;19:3289-302. [PMID: 33131409 DOI: 10.1080/15384101.2020.1839701] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
257 Mittal S, Subramanyam D, Dey D, Kumar RV, Rangarajan A. Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis. Mol Cancer. 2009;8:128. [PMID: 20030805 DOI: 10.1186/1476-4598-8-128] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 7.2] [Reference Citation Analysis]
258 Kuol N, Stojanovska L, Apostolopoulos V, Nurgali K. Role of the Nervous System in Tumor Angiogenesis. Cancer Microenviron 2018;11:1-11. [PMID: 29502307 DOI: 10.1007/s12307-018-0207-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
259 Wang Y, Hou H, Li M, Yang Y, Sun L. Anticancer effect of eupatilin on glioma cells through inhibition of the Notch-1 signaling pathway. Mol Med Rep 2016;13:1141-6. [PMID: 26676446 DOI: 10.3892/mmr.2015.4671] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
260 Bellon M, Moles R, Chaib-Mezrag H, Pancewicz J, Nicot C. JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells. J Hematol Oncol 2018;11:119. [PMID: 30231940 DOI: 10.1186/s13045-018-0665-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
261 Ramamoorthy P, Dandawate P, Jensen RA, Anant S. Celastrol and Triptolide Suppress Stemness in Triple Negative Breast Cancer: Notch as a Therapeutic Target for Stem Cells. Biomedicines 2021;9:482. [PMID: 33924995 DOI: 10.3390/biomedicines9050482] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
262 Izrailit J, Berman HK, Datti A, Wrana JL, Reedijk M. High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer. Proc Natl Acad Sci U S A 2013;110:1714-9. [PMID: 23319603 DOI: 10.1073/pnas.1214014110] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 8.9] [Reference Citation Analysis]
263 Chivukula IV, Ramsköld D, Storvall H, Anderberg C, Jin S, Mamaeva V, Sahlgren C, Pietras K, Sandberg R, Lendahl U. Decoding breast cancer tissue-stroma interactions using species-specific sequencing. Breast Cancer Res 2015;17:109. [PMID: 26265142 DOI: 10.1186/s13058-015-0616-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
264 Colbert LS, Wilson K, Kim S, Liu Y, Oprea-Ilies G, Gillespie C, Dickson T, Newman G, Gonzalez-Perez RR. NILCO biomarkers in breast cancer from Chinese patients. BMC Cancer. 2014;14:249. [PMID: 24716804 DOI: 10.1186/1471-2407-14-249] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
265 Huang T, Zhou Y, Cheng AS, Yu J, To KF, Kang W. NOTCH receptors in gastric and other gastrointestinal cancers: oncogenes or tumor suppressors? Mol Cancer 2016;15:80. [PMID: 27938406 DOI: 10.1186/s12943-016-0566-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
266 Yan B, Liu L, Zhao Y, Xiu LJ, Sun DZ, Liu X, Lu Y, Shi J, Zhang YC, Li YJ, Wang XW, Zhou YQ, Feng SH, Lv C, Wei PK, Qin ZF. Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells. World J Gastroenterol 2014; 20(36): 13105-13118 [PMID: 25278704 DOI: 10.3748/wjg.v20.i36.13105] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
267 Wang Z, Li Y, Kong D, Sarkar FH. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr Drug Targets. 2010;11:745-751. [PMID: 20041844 DOI: 10.2174/138945010791170860] [Cited by in Crossref: 180] [Cited by in F6Publishing: 179] [Article Influence: 15.0] [Reference Citation Analysis]
268 Myers MV, Manning HC, Coffey RJ, Liebler DC. Protein expression signatures for inhibition of epidermal growth factor receptor-mediated signaling. Mol Cell Proteomics 2012;11:M111.015222. [PMID: 22147731 DOI: 10.1074/mcp.M111.015222] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
269 Zhang H, Wang X, Xu J, Sun Y. Notch1 activation is a poor prognostic factor in patients with gastric cancer. Br J Cancer. 2014;110:2283-2290. [PMID: 24642622 DOI: 10.1038/bjc.2014.135] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
270 Meng RD, Shelton CC, Li YM, Qin LX, Notterman D, Paty PB, Schwartz GK. gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Res. 2009;69:573-582. [PMID: 19147571 DOI: 10.1158/0008-5472.can-08-2088] [Cited by in Crossref: 187] [Cited by in F6Publishing: 123] [Article Influence: 14.4] [Reference Citation Analysis]
271 Piwarski SA, Thompson C, Chaudhry AR, Denvir J, Primerano DA, Fan J, Salisbury TB. The putative endogenous AHR ligand ITE reduces JAG1 and associated NOTCH1 signaling in triple negative breast cancer cells. Biochem Pharmacol 2020;174:113845. [PMID: 32032581 DOI: 10.1016/j.bcp.2020.113845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
272 Al-Awaida WJ, Hameed WS, Al Hassany HJ, Al-Dabet MM, Al-Bawareed O, Hadi NR. Evaluation of the Genetic Association and Expressions of Notch-2 /Jagged-1 in Patients with Type 2 Diabetes Mellitus. Med Arch 2021;75:101-8. [PMID: 34219868 DOI: 10.5455/medarh.2021.75.101-108] [Reference Citation Analysis]
273 Wang T, Xuan X, Pian L, Gao P, Hu H, Zheng Y, Zang W, Zhao G. Notch-1-mediated esophageal carcinoma EC-9706 cell invasion and metastasis by inducing epithelial-mesenchymal transition through Snail. Tumour Biol 2014;35:1193-201. [PMID: 24022665 DOI: 10.1007/s13277-013-1159-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
274 Oktem G, Bilir A, Uslu R, Inan SV, Demiray SB, Atmaca H, Ayla S, Sercan O, Uysal A. Expression profiling of stem cell signaling alters with spheroid formation in CD133high/CD44high prostate cancer stem cells. Oncol Lett 2014;7:2103-9. [PMID: 24932297 DOI: 10.3892/ol.2014.1992] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
275 Lino MM, Merlo A, Boulay JL. Notch signaling in glioblastoma: a developmental drug target? BMC Med. 2010;8:72. [PMID: 21078177 DOI: 10.1186/1741-7015-8-72] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
276 Sun W, Gaykalova DA, Ochs MF, Mambo E, Arnaoutakis D, Liu Y, Loyo M, Agrawal N, Howard J, Li R. Activation of the NOTCH pathway in head and neck cancer. Cancer Res. 2014;74:1091-1104. [PMID: 24351288 DOI: 10.1158/0008-5472.can-13-1259] [Cited by in Crossref: 137] [Cited by in F6Publishing: 91] [Article Influence: 15.2] [Reference Citation Analysis]
277 Pandya K, Wyatt D, Gallagher B, Shah D, Baker A, Bloodworth J, Zlobin A, Pannuti A, Green A, Ellis IO, Filipovic A, Sagert J, Rana A, Albain KS, Miele L, Denning MF, Osipo C. PKCα Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab Resistance. Clin Cancer Res 2016;22:175-86. [PMID: 26350262 DOI: 10.1158/1078-0432.CCR-15-0179] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
278 Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, Shetty K, Johnson L, Reddy EP. Liver stem cells and hepatocellular carcinoma. Hepatology. 2009;49:318-329. [PMID: 19111019 DOI: 10.1002/hep.22704] [Cited by in Crossref: 224] [Cited by in F6Publishing: 218] [Article Influence: 17.2] [Reference Citation Analysis]
279 San Juan BP, Garcia-Leon MJ, Rangel L, Goetz JG, Chaffer CL. The Complexities of Metastasis. Cancers (Basel) 2019;11:E1575. [PMID: 31623163 DOI: 10.3390/cancers11101575] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
280 Zhou Y, Liu Y, Li K, Zhang R, Qiu F, Zhao N, Xu Y. ICan: an integrated co-alteration network to identify ovarian cancer-related genes. PLoS One 2015;10:e0116095. [PMID: 25803614 DOI: 10.1371/journal.pone.0116095] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
281 Hao B, Chen X, Cao Y. Yes-associated protein 1 promotes the metastasis of U251 glioma cells by upregulating Jagged-1 expression and activating the Notch signal pathway. Exp Ther Med 2018;16:1411-6. [PMID: 30112068 DOI: 10.3892/etm.2018.6322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
282 Oskarsson T, Acharyya S, Zhang XH, Vanharanta S, Tavazoie SF, Morris PG, Downey RJ, Manova-Todorova K, Brogi E, Massagué J. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med. 2011;17:867-874. [PMID: 21706029 DOI: 10.1038/nm.2379] [Cited by in Crossref: 562] [Cited by in F6Publishing: 530] [Article Influence: 51.1] [Reference Citation Analysis]
283 Chinchar E, Makey KL, Gibson J, Chen F, Cole SA, Megason GC, Vijayakumar S, Miele L, Gu JW. Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells. Vasc Cell. 2014;6:12. [PMID: 24914410 DOI: 10.1186/2045-824x-6-12] [Cited by in Crossref: 52] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
284 Paryan M, Tavakoli R, Rad SMAH, Feizi N, Kamani F, Mostafavi E, Mohammadi-Yeganeh S. Over-expression of NOTCH1 as a biomarker for invasive breast ductal carcinoma. 3 Biotech 2016;6:58. [PMID: 28330128 DOI: 10.1007/s13205-016-0373-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
285 Peng GL, Tian Y, Lu C, Guo H, Zhao XW, Guo YW, Wang LQ, Du QL, Liu CP. Effects of Notch-1 down-regulation on malignant behaviors of breast cancer stem cells. J Huazhong Univ Sci Technolog Med Sci 2014;34:195-200. [PMID: 24710932 DOI: 10.1007/s11596-014-1258-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
286 Pradeep CR, Köstler WJ, Lauriola M, Granit RZ, Zhang F, Jacob-Hirsch J, Rechavi G, Nair HB, Hennessy BT, Gonzalez-Angulo AM, Tekmal RR, Ben-Porath I, Mills GB, Domany E, Yarden Y. Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling. Oncogene 2012;31:907-17. [PMID: 21743488 DOI: 10.1038/onc.2011.279] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
287 Kim SH, Sehrawat A, Singh SV. Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration. Breast Cancer Res Treat 2012;134:1067-79. [PMID: 22476855 DOI: 10.1007/s10549-012-2043-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
288 Masiero M, Li D, Whiteman P, Bentley C, Greig J, Hassanali T, Watts S, Stribbling S, Yates J, Bealing E, Li JL, Chillakuri C, Sheppard D, Serres S, Sarmiento-Soto M, Larkin J, Sibson NR, Handford PA, Harris AL, Banham AH. Development of Therapeutic Anti-JAGGED1 Antibodies for Cancer Therapy. Mol Cancer Ther 2019;18:2030-42. [PMID: 31395687 DOI: 10.1158/1535-7163.MCT-18-1176] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
289 DeCotiis JL, Lukac DM. KSHV and the Role of Notch Receptor Dysregulation in Disease Progression. Pathogens 2017;6:E34. [PMID: 28777778 DOI: 10.3390/pathogens6030034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
290 Guo H, Lu Y, Wang J, Liu X, Keller ET, Liu Q, Zhou Q, Zhang J. Targeting the Notch signaling pathway in cancer therapeutics. Thorac Cancer 2014;5:473-86. [PMID: 26767041 DOI: 10.1111/1759-7714.12143] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
291 Sanguinetti A, Santini D, Bonafè M, Taffurelli M, Avenia N. Interleukin-6 and pro inflammatory status in the breast tumor microenvironment. World J Surg Oncol 2015;13:129. [PMID: 25881039 DOI: 10.1186/s12957-015-0529-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
292 Clementz AG, Rogowski A, Pandya K, Miele L, Osipo C. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications. Breast Cancer Res. 2011;13:R63. [PMID: 21679465 DOI: 10.1186/bcr2900] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
293 Li Y, Ye J, Chen Z, Wen J, Li F, Su P, Lin Y, Hu B, Wu D, Ning L, Xue Q, Gu H, Ning Y. Annonaceous acetogenins mediated up-regulation of Notch2 exerts growth inhibition in human gastric cancer cells in vitro. Oncotarget 2017;8:21140-52. [PMID: 28416750 DOI: 10.18632/oncotarget.15502] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
294 Salem ML, El-Badawy AS, Li Z. Immunobiology and signaling pathways of cancer stem cells: implication for cancer therapy. Cytotechnology. 2015;67:749-759. [PMID: 25516358 DOI: 10.1007/s10616-014-9830-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
295 Cheng Y, Lin L, Li X, Lu A, Hou C, Wu Q, Hu X, Zhou Z, Chen Z, Tang F. ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc. Cancer Cell Int 2021;21:32. [PMID: 33413403 DOI: 10.1186/s12935-020-01727-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
296 Banerjee D, Hernandez SL, Garcia A, Kangsamaksin T, Sbiroli E, Andrews J, Forrester LA, Wei N, Kadenhe-Chiweshe A, Shawber CJ, Kitajewski JK, Kandel JJ, Yamashiro DJ. Notch suppresses angiogenesis and progression of hepatic metastases. Cancer Res 2015;75:1592-602. [PMID: 25744722 DOI: 10.1158/0008-5472.CAN-14-1493] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
297 Simmons MJ, Serra R, Hermance N, Kelliher MA. NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitro. Breast Cancer Res 2012;14:R126. [PMID: 22992387 DOI: 10.1186/bcr3321] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]